TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Enovis Surgical Sweden AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
27,172
|
27,917
|
22,342 |
| Financial expenses |
697
|
619
|
1,438 |
| Earnings before taxes |
-940
|
495
|
666 |
| EBITDA |
2,672
|
4,915
|
6,180 |
| Total assets |
24,661
|
31,863
|
27,739 |
| Current assets |
18,736
|
24,601
|
19,494 |
| Current liabilities |
11,866
|
13,249
|
9,678 |
| Equity capital |
1,265
|
2,205
|
1,678 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
5.1%
|
6.9%
|
6.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-3.5%
|
1.8%
|
3.0% |
| Return on assets (ROA) |
-1.0%
|
3.5%
|
7.6% |
| Current ratio |
157.9%
|
185.7%
|
201.4% |
| Return on equity (ROE) |
-74.3%
|
22.4%
|
39.7% |
| Change turnover |
-745
|
5,575
|
5,589 |
| Change turnover % |
-3%
|
25%
|
33% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.